Reply

[Article in English, Spanish]

Affiliations

¹ Unidad de Enfermedades Autoinmunes, Hospital Evangélico y Centro Asistencial del Sindicato Médico del Uruguay (CASMU), Montevideo, Uruguay; Laboratorio de Inmunorregulación e Inflamación, Institut Pasteur de Montevideo, Montevideo, Uruguay.
² Servicio de Enfermedades Autoinmunes, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, España. Electronic address: gespino@clinic.cat.

Comment

[Article in English, Spanish]

Ernesto Cairoli et al. Med Clin (Barc). 2022.

. 2022 Jul 8;159(1):e4.

doi: 10.1016/j.medcli.2022.01.010. Epub 2022 Mar 14.

¹ Unidad de Enfermedades Autoinmunes, Hospital Evangélico y Centro Asistencial del Sindicato Médico del Uruguay (CASMU), Montevideo, Uruguay; Laboratorio de Inmunorregulación e Inflamación, Institut Pasteur de Montevideo, Montevideo, Uruguay.
² Servicio de Enfermedades Autoinmunes, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, España. Electronic address: gespino@clinic.cat.

No abstract available

Comment on

Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios.
Cairoli E, Espinosa G. Cairoli E, et al. Med Clin (Engl Ed). 2021 Sep 10;157(5):247-252. doi: 10.1016/j.medcle.2021.05.003. Epub 2021 Aug 7. Med Clin (Engl Ed). 2021. PMID: 34395909 Free PMC article. No abstract available.
Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios.
Calvo Elías AE, Pérez Casado L, Callejas Rubio JL. Calvo Elías AE, et al. Med Clin (Barc). 2022 Jul 8;159(1):e3. doi: 10.1016/j.medcli.2021.10.007. Epub 2021 Nov 13. Med Clin (Barc). 2022. PMID: 34903377 Free PMC article. English, Spanish. No abstract available.

1. Mélet J., Mulleman D., Goupille P., Ribourtout B., Watier H., Thibault G. Rituximab-induced T cell depletion in patients with rheumatoid arthritis. Arthritis Rheum. 2013;65:2783–2790. - PubMed
1. Cairoli E., Espinosa G. Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios. Med Clin (Barc) 2021;157:247–252. doi: 10.1016/j.medcle.2021.05.003. - DOI - PMC - PubMed
1. Moor M.B., Suter-Riniker F., Horn M.P., Aberli D., Amsler J., Möller B., et al. Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): An investigator-initiated, single-cente, open-label study. Lancet Rheumatol. 2021:e789–e797. doi: 10.1016/S2665-9913/21)00251-4. - DOI - PMC - PubMed
1. Mrak D., Tobudic S., Koblischke M., Graninger M., Radner H., Sieghart D., et al. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity. Ann Rheum Dis. 2021;80:1345–1350. doi: 10.1136/annrheumdis-2021-220781. - DOI - PubMed
1. Strangfeld A., Schäfer M., Gianfrancesco M.A., Lawson-Tovey S., Liew J.W., Ljung L., et al. Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021;80:930–942. doi: 10.1136/annrheumdis-2020-219498. - DOI - PMC - PubMed